What is The Beauty Health Company's R&D?

The Beauty Health Company (SKIN) reported R&D of $1.1M in Q1 2026.

How has The Beauty Health Company's R&D changed year-over-year?

The Beauty Health Company's R&D increased by 10.4% year-over-year, from $998K to $1.1M.

What is the long-term trend for The Beauty Health Company's R&D?

Over 4 years (2021 to 2025), The Beauty Health Company's R&D has grown at a -9.0% compound annual growth rate (CAGR), from $8.2M to $5.63M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

The Beauty Health Company SKIN R&D

R&D at other companies

Solesence, Inc. Common StockSLSN

$1.04M+2.4%

SANUWAVE Health, Inc.SNWV

$660K+217%

Journey Medical CorporationDERM

$154K-29.4%

PROCEPT BioRobotics CorporationPRCT

$21.47M+30.9%

iRadimedIRMD

$956K+53.2%

Other financials

Income statement

See full

Revenue$64.9M-6.7%

Gross profit$44.4M-8.5%

Operating income-$1.8M+85.0%

Net income-$6.6M+34.3%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$204.4M-45.2%

Total debt$125.9M+756%

Total equity$55.2M+19.9%

Total assets$473.2M-29.8%

Cash flow

See full

Operating cash flow-$5.6M-285%

CapEx$224.0K+398%

Free cash flow-$5.8M-296%

Valuation

See full

Market cap$89.75M-63.3%

Enterprise value$11.24M-97.3%

P/S0.3×-0.5×

Profitability

See full

Gross margin64.9%+8.3pp

Operating margin-3.6%-1.6pp

Net margin-2%-0.9pp

FCF margin9.6%—

Returns & leverage

See full

Return on equity-12%-5.4pp

Debt / equity2.3×+2.0×

Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Beauty Health Company's R&D?: The Beauty Health Company (SKIN) reported R&D of $1.1M in Q1 2026.
How has The Beauty Health Company's R&D changed year-over-year?: The Beauty Health Company's R&D increased by 10.4% year-over-year, from $998K to $1.1M.
What is the long-term trend for The Beauty Health Company's R&D?: Over 4 years (2021 to 2025), The Beauty Health Company's R&D has grown at a -9.0% compound annual growth rate (CAGR), from $8.2M to $5.63M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.